We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:
Medicine & public health

Search Results

Showing 81-100 of 3,817 results

  1. Long-term outcome after allogeneic stem cell transplantation in multiple myeloma

    The role of allogeneic hematopoietic stem cell transplantation (allo-SCT) in multiple myeloma is controversial. We analyzed the results of 205...

    Sini Luoma, Raija Silvennoinen, ... Anne Nihtinen in Annals of Hematology
    Article Open access 17 April 2021

  2. How risky is a second allogeneic stem cell transplantation?

    There is no consensus on second allogeneic stem cell transplantation (alloSCT) indications in patients with hematologic malignancies relapsing after...

    Olaf Penack, Mouad Abouqateb, ... Zinaida Peric in Leukemia
    Article Open access 25 June 2024

  3. Psychosocial correlates of physical activity in cancer survivors: a systematic review and meta-analysis

    Background

    Physical activity (PA) is a non-pharmacological approach to optimize health benefits in cancer survivors and is recommended as part of...

    Bruno Rodrigues, Jorge Encantado, ... Eliana V. Carraça in Journal of Cancer Survivorship
    Article Open access 06 March 2024

  4. No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease

    Patients with advanced Ewing sarcoma (AES) carry a poor prognosis. Retrospectively, we analyzed 66 AES patients treated with allogeneic stem cell...

    U. Thiel, S. J. Schober, ... P. Lang in Bone Marrow Transplantation
    Article Open access 29 January 2021

  5. The utility of hyperbaric oxygen therapy in post-transplant cyclophosphamide-induced hemorrhagic cystitis: a case report and review of the literature

    Background

    To date, there are only a few case reports of cyclophosphamide (Cy)-induced hemorrhagic cystitis (HC) in adult or pediatric allogeneic stem...

    Moayed Ibrahim, Kshama Bhyravabhotla, ... Francisco Socola in Journal of Medical Case Reports
    Article Open access 04 January 2021

  6. Desensitization Strategies for Donor-Specific Antibodies in HLA-Mismatched Stem Cell Transplantation Recipients: What We Know and What We Do Not Know

    In human leukocyte antigen (HLA)-mismatched allogeneic stem cell transplantation settings, donor-specific anti-HLA antibodies (DSAs) can...

    Yang Zhou, Yu-Lun Chen, ... Ying-Jun Chang in Oncology and Therapy
    Article Open access 15 June 2024

  7. Impact of donor types on reduced-intensity conditioning allogeneic stem cell transplant for mature lymphoid malignancies

    We retrospectively compared the outcomes of reduced-intensity conditioning (RIC) transplantation from matched related donors (MRD; n = 266), matched...

    Nobuhiko Imahashi, Seitaro Terakura, ... Junya Kanda in Bone Marrow Transplantation
    Article 24 November 2021

  8. Factors affecting the learning curve in robotic colorectal surgery

    Learning related to robotic colorectal surgery can be measured by surgical process (such as time or adequacy of resection) or patient outcome (such...

    Shing Wai Wong, Philip Crowe in Journal of Robotic Surgery
    Article Open access 01 February 2022

  9. The non-steroidal anti-inflammatory drug salsalate provides safe and effective control of mucositis-unrelated pain during autologous and allogeneic hematopoietic stem cell transplantation

    Introduction

    Pain is a serious adverse event which frequently accompanies hematopoietic stem cell transplantation (HSCT). The safety and efficacy of...

    S. Trifilio, L. Gordon, ... J. Mehta in Supportive Care in Cancer
    Article 12 November 2020

  11. Outcome of stem cell transplantation for Waldenström’s macroglobulinemia: analysis of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Lymphoma Working Group

    The role of stem cell transplantation (SCT) for patients with Waldenström’s macroglobulinemia (WM) remains undetermined. Therefore, we...

    Masatoshi Sakurai, Takehiko Mori, ... Ritsuro Suzuki in Annals of Hematology
    Article 18 May 2020

  12. Pre-emptive and prophylactic donor lymphocyte infusion following allogeneic stem cell transplantation

    Donor lymphocyte infusion (DLI) is an allogenic immunotherapy used after allogeneic hematopoietic stem cell transplantation. DLI takes advantage of...

    Kaito Harada in International Journal of Hematology
    Article 04 April 2023

  13. Outcome improvement over time in reduced intensity conditioning hematopoietic transplantation: a 20-year experience

    The current study includes all consecutive patients ( N = 484) who received a reduced-intensity conditioning regimen (RIC) allogeneic hematopoietic...

    Albert Esquirol, Irene Garcia Cadenas, ... Rodrigo Martino in Annals of Hematology
    Article 16 November 2023

  16. Daratumumab for De-sensitization of Donor Specific Antibodies: Is it a Quicker and Easier way?

    Antibodies directed against donor-specific HLA loci (DSA) has been proved as a main culprit for graft rejection, more specifically in HLA mismatched...

    Pallavi Mehta, Santosh Raut, ... Rahul Bhargava in Indian Journal of Hematology and Blood Transfusion
    Article 24 November 2023

  17. Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC

    Allogeneic stem cell transplantation (allo-SCT) represents the most beneficial treatment for patients with active relapsed/refractory (R/R)...

    Amandine Le Bourgeois, Myriam Labopin, ... Patrice Chevallier in Annals of Hematology
    Article 20 June 2020

  18. Weight loss post-allogeneic stem cell transplant is associated with increased transplant-related mortality

    Purpose

    Allogeneic stem cell transplant (allo-HSCT) patients are at risk of malnutrition and weight loss from impaired oral intake resulting from...

    Kayla Madsen, Katherine Lee, ... Jonas Mattsson in Supportive Care in Cancer
    Article 07 September 2023

  19. Richter Transformation of Chronic Lymphocytic Leukemia—Are We Making Progress?

    Purpose of Review

    The treatment paradigm of chronic lymphocytic leukemia (CLL) has dramatically changed with the advent of novel targeted agents over...

    Hadiyah Y. Audil, Samuel R. Kosydar, ... Sameer A. Parikh in Current Hematologic Malignancy Reports
    Article 09 June 2023

  20. Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party—EBMT

    Autologous hematopoietic stem cell transplantation (ASCT) is curative for a proportion of patients with relapsed/refractory (R/R) Hodgkin lymphoma...

    Leyre Bento, Ariane Boumendil, ... Anna Sureda in Bone Marrow Transplantation
    Article 12 October 2020
Did you find what you were looking for? Share feedback.